Initial drug resistance and tuberculosis treatment outcomes: systematic review and meta-analysis.
摘要：
Despite the increasing prevalence of drug-resistant tuberculosis, most low- and middle-income countries use standardized regimens, without assessment of drug susceptibility.To perform a systematic review and meta-analysis of the effect of initial drug resistance and treatment regimen on tuberculosis treatment outcomes.PubMed, the Cochrane Central Database of Clinical Trials, and EMBASE were searched for studies published in English from 1965 to June 2007. Additional studies were identified from cited references.Randomized, controlled trials and cohort studies of standardized treatment of previously untreated patients with culture-confirmed pulmonary tuberculosis. Drug-susceptibility testing was done on pretreatment isolates from all patients and from patients with treatment failure or relapse.Two authors reviewed the studies for methods, initial drug resistance, treatment regimens, and outcomes.Pooled cumulative incidences were computed with random-effects meta-analyses. Association between risk factors and outcomes were determined by using stratified analyses. The cumulative incidence of acquired drug resistance with initially pan-sensitive strains was 0.8% (95% CI, 0.5% to 1.0%) compared with 6% (CI, 4% to 8%) with initially single drug-resistant strains and 14% (CI, 9% to 20%) with initially polydrug-resistant strains. Failure and relapse were most strongly associated with initial drug resistance. Failure was also associated with shorter duration of rifampin therapy and nonuse of streptomycin, whereas the rate of relapse was higher with shorter duration of rifampin therapy and nonuse of pyrazinamide.Few studies included HIV-infected persons, and treatment outcomes were pooled despite considerable heterogeneity.Treatment outcomes were substantially worse in the presence of initial drug resistance, which has important implications in resource-limited settings in which drug resistance is prevalent.
展开
关键词：
Antitubercular Agents Drug Resistance, Bacterial Humans Mycobacterium tuberculosis 抗结核药 分支杆菌, 结核 治疗结果 结核, 肺
DOI：
10.7326/0003-4819-149-2-200807150-00008
被引量：
年份：
2008
国家科技图书文献中心
(权威机构)
EBSCO
BMJ
掌桥科研
万方医学
查看更多
dx.doi.org
Oxford Univ Press
NCBI
NCBI
BioMed Central
Europe PMC
NRC Research Press
ProQuest
ResearchGate
EBSCO
Citeseer
(全网免费下载)
EBSCO
rsif.royalsocietypublishing.org
cmr.asm.org
elifesciences.org
erj.ersjournals.com
deepdyve.com
scienceopen.com
pubfacts.com
mysciencework.com
pherobase.com
mendeley.com
nejm.org
annals.org
onAcademic
Citeseer
(全网免费下载)
通过文献互助平台发起求助，成功后即可免费获取论文全文。
相似文献
参考文献
引证文献
引用走势
站内活动
辅助模式
引用
文献可以批量引用啦~
欢迎点我试用！
